Bain Capital Public Equity Management Ii, LLC Moderna, Inc. Transaction History
Bain Capital Public Equity Management Ii, LLC
- $1.77 Billion
- Q4 2024
A detailed history of Bain Capital Public Equity Management Ii, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Bain Capital Public Equity Management Ii, LLC holds 25,700 shares of MRNA stock, worth $918,775. This represents 0.22% of its overall portfolio holdings.
Number of Shares
25,700Holding current value
$918,775% of portfolio
0.22%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRNA
# of Institutions
919Shares Held
255MCall Options Held
19MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.44 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.39 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$914 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$628 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$261 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...